Greenpro Capital Corp
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
NOTE 1 –NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Greenpro Inc. (the “Company”) was incorporated on July 19, 2013, in the state of Nevada, and in 2015 changed its name to Greenpro Capital Corp. The Company currently provides a wide range of business consulting and corporate advisory services including cross-border listing advisory services, tax planning, advisory and transaction services, record management services, and accounting outsourcing services. As part of our business consulting and corporate advisory business segment, our subsidiary, Greenpro Venture Capital Limited (“GVCL”) provides a business incubator for start-up and high growth companies during their critical growth period and focuses on investments in select start-up and high growth potential companies. In addition to our business consulting and corporate advisory business segment, we operate another business segment that focuses on the acquisition and rental of real estate properties held for investment and the and sale of real estate properties held for sale. Our focus is on companies located in South-East Asia and East Asia including Hong Kong, the People’s Republic of China (“PRC”), Malaysia, Thailand, and Singapore.
Going Concern
The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, for the year ended December 31, 2023, the Company recorded a net cash used in operations of $1,594,718 and as of December 31, 2023, the Company incurred accumulated deficit of $36,549,095. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its major shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing.
Certain effects of reverse stock split
On July 19, 2022, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada (the “Certificate of Change”) to effect a reverse split of the Company’s Common Stock at a ratio of 10-for-1 (the “Reverse Stock Split”), effective as of July 28, 2022. On that date, every 10 issued and outstanding shares of the Company’s Common Stock were automatically converted into one outstanding share of Common Stock. As a result of the Reverse Stock Split, the number of the outstanding shares of Common Stock decreased from 78,671,688 (pre-split) shares to 7,875,813 (post-split) shares. In addition, by reducing the number of outstanding shares, the Company’s loss per share in all prior periods increased by a factor of 10. The Reverse Stock Split affected all shares of Common Stock outstanding immediately prior to the effective time of the Reverse Stock Split. In addition, the Reverse Stock Split effected a reduction in the number of shares of Common Stock issuable upon the exercise of the warrants outstanding immediately prior to the effectiveness of the Reverse Stock Split, resulting in a reduction from 53,556 (pre-split) shares to 5,356 (post-split) shares (see Note 11).
No fractional shares are issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional shares because they hold a number of pre-reverse stock split shares of the Company’s Common Stock not evenly divisible by 10, in lieu of a fractional share, are entitled the number of shares rounded up to the nearest whole share. The Company will issue one whole share of the post-Reverse Stock Split Common Stock to any stockholder who otherwise would have received a fractional share as a result of the Reverse Stock Split.
The Reverse Stock Split affected all holders of Common Stock uniformly and did not affect any stockholder’s percentage of ownership interest. The par value of the Company’s Common Stock remained unchanged at $0.0001 per share and the number of authorized shares of Common Stock remained the same after the Reverse Stock Split.
As the par value per share of the Company’s Common Stock remained unchanged at $0.0001 per share, the change in the Common Stock recorded at par value has been reclassified to additional paid-in-capital on a retroactive basis. All references to shares of Common Stock and per share data for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted to reflect the Reverse Stock Split on a retroactive basis.
COVID-19 pandemic and other global risks
As a result of the COVID-19 pandemic and actions taken to slow its spread, the ongoing military conflict between Russia and Ukraine, the armed conflict in Sudan, and other geopolitical and macroeconomic factors beyond our control, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability.
On March 10, 2023, the Federal Deposit Insurance Corporation took control and was appointed receiver of Silicon Valley Bank. While we did not have deposits at Silicon Valley Bank, if other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, our ability to access our existing cash, cash equivalents and investments may be threatened and could have a material adverse effect on our business and financial condition. It is possible that further deterioration in credit and financial markets and confidence in economic conditions will occur. If equity and credit markets deteriorate, it may affect our ability to raise equity capital, borrow on our existing facilities, access our existing cash, or make any additional necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive.
Basis of presentation and principles of consolidation
The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries and a majority-owned subsidiary which the Company controls and entities for which the Company is the primary beneficiary. For those consolidated subsidiaries where the Company’s ownership is less than 100%, the outside shareholders’ interests are shown as noncontrolling interests in equity. Acquired businesses are included in the consolidated financial statements from the dates of acquisition. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. All inter-company accounts and transactions have been eliminated in consolidation.
Use of estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates include certain assumptions related to, among others, the allowance for credit losses, impairment analysis of real estate assets and other long-term assets including goodwill, estimates inherent in recording purchase price allocation, valuation allowance on deferred income taxes, the assumptions used in the valuation of the derivative liability, and the accrual of potential liabilities. Actual results may differ from these estimates.
Credit losses
The Company estimates and records a provision for its expected credit losses related to its financial instruments, including its trade receivables. Management considers historical collection rates, the current financial status of the Company’s customers, macroeconomic factors, and other industry-specific factors when evaluating current expected credit losses. Forward-looking information is also considered in the evaluation of current expected credit losses. However, because of the short time to the expected receipt of accounts receivable, management believes that the carrying value, net of expected losses, approximates fair value and therefore, relies more on historical and current analysis of such financial instruments, including its trade receivables.
To determine the provision for credit losses for accounts receivable, the Company has disaggregated its accounts receivable by class of customer at the business component level, as management determined that risk profile of the Company’s customers is consistent based on the type and industry in which they operate, mainly in the pharmaceuticals industry. Each business component is analyzed for estimated credit losses individually. In doing so, the Company establishes a historical loss matrix, based on the previous collections of accounts receivable by the age of such receivables, and evaluates the current and forecasted financial position of its customers, as available. Further, the Company considers macroeconomic factors and the status of the pharmaceuticals industry to estimate if there are current expected credit losses within its trade receivables based on the trends of the Company’s expectation of the future status of such economic and industry-specific factors. Also, specific allowance amounts are established based on review of outstanding invoices to record the appropriate provision for customers that have a higher probability of default.
Accounts receivable at December 31, 2023 and 2022 are net of allowances for credit losses of $610,599 and $25,677, respectively. The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected at December 31, 2023 and 2022:
| As of and for the years ended, | ||
|---|---|---|
| 2023 | 2022 | |
| Balance at beginning of year | $25,677 | $133,356 |
| Charged to operating expenses | 584,919 | 19,075 |
| Write-offs of accounts receivable, net of recoveries | 3 | (126,754) |
| Balance at end of year | $610,599 | $25,677 |
Revenue recognition
The Company follows the guidance of Accounting Standards Codification (ASC) 606,Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients (see Note 2).
Cash and cash equivalents
Cash consists of funds on hand and held in bank accounts. Cash equivalents includes time deposits placed with banks or other financial institutions and all highly liquid investments with original maturities of three months or less, including money market funds.
On December 31, 2023, and 2022, cash included funds held by employees of $0 and $11,464, respectively, was to facilitate payment of expenses in local currencies or to facilitate third-party online payment platforms which the Company had not set up a corporate account, such as WeChat Pay or Alipay.
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cash and cash equivalents | ||
| Denominated in United States Dollar | $573,431 | $2,234,242 |
| Denominated in Hong Kong Dollar | 1,175,384 | 1,201,076 |
| Denominated in Chinese Renminbi | 434,698 | 381,012 |
| Denominated in Malaysian Ringgit | 39,552 | 85,940 |
| Denominated in Great British Pound | 127 | - |
| Denominated in Singapore Dollar | 5 | 65 |
| Denominated in Euro | - | 9,200 |
| Cash and cash equivalents | $2,223,197 | $3,911,535 |
Accounts receivable, net
Accounts receivable is recorded at the invoiced amount less an allowance for any uncollectible accounts. Management reviews the adequacy of the allowance for credit losses on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history and the current economic conditions to make an adjustment to the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Accounts receivable, gross | $655,537 | $195,214 |
| Less: Allowance for credit losses | (610,599) | (25,677) |
| Accounts receivable, net | $44,938 | $169,537 |
Property and equipment, net
Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated on the straight-line basis over the following estimated useful lives:
| Categories | Estimated useful life |
|---|---|
| Office leasehold | 27 years |
| Furniture and fixtures | 3 - 10 years |
| Office equipment | 3 - 10 years |
| Leasehold improvement | Over the shorter of estimated useful life or term of lease |
Office leasehold includes in property and equipment representing three adjoining office units used by the Company located in a commercial building in Shenzhen, China. The office leasehold is subject to a land lease with a term of 27 years and is being depreciated over the remaining lease term. Expenditures for maintenance and repairs are expensed as incurred. Depreciation for this office leasehold in Shenzhen, China, classified as an operating expense, was $104,442 and $111,707 for the years ended December 31, 2023, and 2022, respectively (see Note 3).
Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2023, and 2022, the Company determined there were no indicators of impairment of its property and equipment (see Note 3).
Real estate held for sale
Real estate held for sale is reported at the lower of carrying amount or fair value, less estimated costs to sell. The cost of real estate held for sale includes the purchase price of property, legal fees, improvement costs to the building structure, and other acquisition costs. We actively market all properties that are designated as held for sale. Real estate held for sale is not depreciated.
In conducting its reviews for indicators of impairment, the Company evaluates, among other things, the margins on units already sold within the project, margins on units under contract but not closed, and projected margins on future unit sales. The Company pays close attention to discern if the real estate held for sale is moving at a slower than expected pace or where margins are trending downward. For the years ended December 31, 2023, and 2022, the Company determined there were no indicators of impairment of its real estate held for sale (see Note 4).
Real estate held for investment, net
Real estate held for investment is stated at cost less accumulated depreciation. Depreciation is calculated on the straight-line basis over the following estimated useful lives:
| Categories | Estimated useful life |
|---|---|
| Office leasehold | 50 years |
| Furniture and fixtures | 3 - 10 years |
| Office equipment | 3 - 10 years |
| Leasehold improvement | Shorter of the estimated useful life or term of lease |
Office leasehold includes in real estate held for investment representing three office units owned by the Company located in two commercial buildings in Kuala Lumpur, Malaysia.
Depreciation for this office leasehold in Kuala Lumpur, Malaysia, classified as cost of rental, was $25,125 and $29,001 for the years ended December 31, 2023, and 2022, respectively (see Note 5).
Management assesses the carrying value of real estate held for investment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2023, and 2022, the Company determined there were no indicators of impairment of its real estate held for investment (see Note 5).
Intangible assets, net
Amortizable identifiable intangible assets are stated at cost less accumulated amortization and represent certain trademarks registered in USA, Hong Kong, China, and Singapore.
Amortization is calculated on the straight-line basis over the following estimated useful lives:
| Categories | Estimated useful life |
|---|---|
| Trademarks | 10 years |
Amortization expense was $718 for the years ended December 31, 2023, and 2022, respectively.
The Company follows ASC 360 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. For the years ended December 31, 2023, and 2022, the Company determined there were no indicators of impairment of intangible assets (see Note 7).
Goodwill
Goodwill is the excess of cost of an acquired entity over the fair value of amounts assigned to assets acquired and liabilities assumed in a business combination. Under the guidance of ASC 350, goodwill is not amortized, rather it is tested for impairment annually, and will be tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss generally would be recognized when the carrying amount of the reporting unit’s net assets exceeds the estimated fair value of the reporting unit and would be measured as the excess carrying value of goodwill over the derived fair value of goodwill. The Company’s policy is to perform an annual impairment testing for its reporting units on December 31, of each fiscal year.
During 2022, indicators of impairment were present, and hence, the Company made an impairment of goodwill of $263,247. As a result, the value of goodwill was impaired to $82,561 as of December 31, 2022.
For the year ended December 31, 2023, the Company determined there was no indicator of impairment, so no impairment was made. As a result, the value of its goodwill remains at $82,561 as of December 31, 2023 (see Note 7).
Impairment of long-lived assets
Long-lived assets primarily include property and equipment, real estate held for investment and intangible assets. In accordance with the provision of ASC 360, the Company generally conducts its annual impairment evaluation to its long-lived assets, usually in the fourth quarter of each year, or more frequently if indicators of impairment exist, such as a significant sustained change in the business climate. The recoverability of long-lived assets is measured at the reporting unit level. If the total of the expected undiscounted future net cash flows is less than the carrying amount of the asset, a loss is recognized for the difference between the fair value and carrying amount of the asset.
As of December 31, 2023, and 2022, the Company determined there was no indicator of impairment of its property and equipment, real estate held for investment and intangible assets, respectively.
Investments
Investments in equity securities
The Company accounts for its investments that represent less than 20% ownership, and for which the Company does not have the ability to exercise significant influence, using ASU 2016-01,Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. The Company measure investments in equity securities without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. Gains and losses on these securities are recognized in other income and expenses.
On December 31, 2023, the Company had total twenty-five (25) investments in equity securities without readily determinable fair values, all were related party investments with aggregate value of $100,106. In which, thirteen (13) investments in equity securities without readily determinable fair values were fully impaired and with $nil value (see Note 6).
On December 31, 2022, the Company had total twenty-seven (27) investments in equity securities without readily determinable fair values, all were related party investments with aggregate value of $5,406,106. In which, eleven (11) investments in equity securities without readily determinable fair values were fully impaired and with $nil value (see Note 6).
Leases
Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective January 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity or on our compliance with our financial covenants associated with our loans. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods. The adoption of ASC 842 on January 1, 2019 resulted in the initial recognition of operating lease right-of-use assets of $582,647, lease liabilities for operating leases of $582,647, and a zero cumulative-effect adjustment to accumulated deficit (see Note 8).
Derivative financial instruments
Derivative financial instruments consist of financial instruments that contain a notional amount and one or more underlying variables such as interest rate, security price, variable conversion rate or other variables, require no initial net investment and permit net settlement. The derivative financial instruments may be free-standing or embedded in other financial instruments. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company follows the provision of ASC 815, Derivatives and Hedging for derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. At each reporting date, the Company reviews its convertible securities to determine that their classification is appropriate (see Note 9).
Income taxes
The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain (see Note 12).
The Company conducts major businesses in Hong Kong, China, and Malaysia, and is subject to tax in these jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.
Net income (loss) per share
Basic net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is calculated by dividing the net income (loss) by the weighted average number of common shares outstanding, adjusted for the dilutive effect of outstanding Common Stock equivalents.
On December 31, 2023, there wereno dilutive shares outstanding, while on December 31, 2022, the only outstanding Common Stock equivalents were the outstanding warrants of 5,356 potentially dilutive shares. These warrants have been excluded from the calculation of weighted average shares as the effect would have been anti-dilutive and therefore basic and diluted net income (loss) per share were the same.
Foreign currencies translation
The reporting currency of the Company is the United States Dollars (“US$”) and the accompanying consolidated financial statements have been expressed in US$. In addition, the Company’s operating subsidiaries maintain their books and records in their respective local currency, which consists of Malaysian Ringgit (“MYR”), Renminbi (“RMB”) and Hong Kong Dollars (“HK$”), which is also the respective functional currency of subsidiaries.
In general, for consolidation purposes, if a subsidiary’s functional currency other than US$, its assets and liabilities are translated into US$ using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. Any gains or losses resulting from translation of financial statements of a foreign subsidiary are recorded as a separate component of accumulated other comprehensive income or loss within equity.
Translation of amounts from each foreign currency of the Company into US$ has been made at the following exchange rates for the respective periods:
| As of and for the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Period-end MYR : US$1 exchange rate | 4.59 | 4.40 |
| Period-average MYR : US$1 exchange rate | 4.57 | 4.41 |
| Period-end RMB : US$1 exchange rate | 7.10 | 6.91 |
| Period-average RMB : US$1 exchange rate | 7.08 | 6.75 |
| Period-end HK$ : US$1 exchange rate | 7.81 | 7.81 |
| Period-average HK$ : US$1 exchange rate | 7.83 | 7.83 |
Comprehensive income or loss
Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions or other events and circumstances from non-owner sources. The Company’s accumulated other comprehensive income or loss consists of cumulative foreign currency translation adjustments.
Fair value of financial instruments
The Company follows the guidance of the ASC 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:
| ● | Level 1: Observable inputs such as quoted prices in active markets; |
|---|---|
| ● | Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and |
| ● | Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions |
The Company believes the carrying amount reported in the balance sheet for cash and cash equivalents, accounts receivable, prepaids and other current assets, accounts payable and accrued liabilities, deferred costs of revenue and deferred revenue, and due from or due to related parties, approximate their fair values because of the short-term nature of these financial instruments.
As of December 31, 2023, and 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of derivative liabilities of $0 and $1, respectively (see Note 9).
The following table sets forth a summary of the changes in the estimated fair value of our derivative during the years ended December 31, 2023, and 2022:
| As of and for the years ended, | |||
|---|---|---|---|
| 2023 · 2022 | |||
| Fair value at beginning of year | $1 | $9,935 | |
| Fair value gains of derivative liability associated with warrants | (1) | (9,934) | |
| Fair value at end of year | $ | - | $1 |
Concentrations of risks
For the year ended December 31, 2023, two customers accounted for 20% (10% and 10%, respectively) of the Company’s revenue, and three customers accounted for 39% (14%,13% and 12%, respectively) of the Company’s accounts receivable at year-end.
For the year ended December 31, 2022, one customer accounted for 10% of the Company’s revenue, and two customers accounted for 77% (57% and 20%, respectively) of the Company’s accounts receivable at year-end.
For the year ended December 31, 2023, no vendor accounted for 10% or more of the Company’s cost of revenues, and three vendors accounted for 73% (52%,11% and 10%, respectively) of the Company’s accounts payable at year-end.
For the year ended December 31, 2022, no vendor accounted for 10% or more of the Company’s cost of revenues, and three vendors accounted for 59% (29%,19% and 11%, respectively) of the Company’s accounts payable at year-end.
Exchange rate risk
The Company’s reporting currency is US$ but its major revenues and costs, and a significant portion of its assets and liabilities are also denominated in MYR, RMB or HK$. As a result, the Company is exposed to a foreign exchange risk as its revenues and the results of operations may be affected by fluctuations in the exchange rate between US$ and MYR, US$ and RMB or US$ and HK$. If MYR, RMB or HK$ depreciates against US$, the values of its revenues and assets in MYR, RMB or HK$ may decline accordingly when in translation to the Company’s reporting currency, as its financial statements are presented in US$. The Company does not hold any derivative or other financial instruments that may expose it to a substantial market risk.
Risks and uncertainties
Substantially all the Company’s services are conducted in Hong Kong, China, Malaysia, Thailand, Taiwan, and the South-East Asia region. The Company’s operations are subject to various political and economic risks, including the risks of restrictions on transfer of funds, export duties, quotas and embargoes, changing taxation policies, and political conditions and governmental regulations, and the adverse impact of the coronavirus outbreak.
Recent accounting pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). This ASU reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves and amends the related earnings per share guidance. This standard became effective for the Company beginning on January 1, 2023. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its consolidated financial statements.
In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023, as the Company is qualified as a smaller reporting company. The Company has accordingly adopted ASUs 2019-05 in the preparation of its consolidated financial statements from January 1, 2023. Based on the composition of the Company’s accounts receivable, investment portfolio, and other financial assets, including current market conditions and historical credit loss activity, the adoption of this accounting standard did not have a material impact on the Company’s consolidated financial statementsor disclosures. Specifically, the Company’s estimate of expected credit losses as of January 1, 2023, using its expected credit loss evaluation process described above, resulted in no adjustments to the provision forcredit losses and no cumulative-effect adjustment to accumulated deficit on the adoption date of this standard.
Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
NOTE 2 -REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company’s revenues consist of revenue from provision of business consulting and corporate advisory services (“service revenue”), and revenue from leasing or trading of real estate properties (“real estate revenue”).
Revenue from services
For certain service contracts, we assist or provide advisory to clients in capital market listings (“listing services”), our services provided to clients are considered as our performance obligations. Revenue and expenses are deferred until the performance obligation is complete and collectability of the consideration is probable. For service contracts where the performance obligation has not been completed, deferred costs of revenue are recorded as incurred and deferred revenue is recorded for any payments received on such yet to be completed performance obligations. On an ongoing basis, management monitors these contracts for profitability and when needed may record a liability if a determination is made that costs will exceed revenue.
For other services such as company secretarial, accounting, financial analysis, insurance brokerage services, and other related services (“non-listing services”), upon our completion of such services, representing our performance obligations are satisfied, and hence, the relevant revenue is recognized. For contracts in which we act as an agent, the Company reports revenue net of expenses paid.
The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining a client contract.
Revenue from leasing of real estate properties
Rental revenue represents lease rental income from the Company’s tenants. The tenants pay in accordance with the terms in the lease agreements and the Company recognizes the income ratably over the lease term as this is the most representative of the pattern in which the benefit is expected to be derived from the underlying asset.
Revenue from trading of real estate properties
The Company follows the guidance of ASC 610-20,Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”), which applies to sales or transfers to noncustomers of nonfinancial assets. Generally, the Company’s sales of its real estate properties are considered a sale of a nonfinancial asset. Under ASC 610-20, the Company derecognizes its asset and recognizes a gain or loss on the sale of the real estate when control of the underlying asset transfers to the buyer.
During 2023, no real estate property was sold. For the year ended December 31, 2022, the Company recognized revenue from the sale of three units of commercial property held for sale.
Cost of revenues
Cost of service revenue primarily consists of employee compensation and related payroll benefits, company formation costs, and other professional fees directly attributable to the services rendered.
Cost of rental revenue primarily includes costs associated with repairs and maintenance, property management fees, insurance, depreciation, and other related administrative costs. Utility expenses are paid directly by tenants.
Cost of real estate properties sold primarily consists of the purchase price of property, legal fees, improvement costs to the building structure, and other acquisition costs. Selling and advertising costs are expensed as incurred.
The following tables provide information about disaggregated revenue based on revenue by service lines and revenue by geographic area:
| For the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue by service lines: | ||
| Corporate advisory – non-listing services | $1,440,818 | $1,419,843 |
| Corporate advisory – listing services | 1,938,778 | 1,305,623 |
| Rental of real estate properties | 98,068 | 108,495 |
| Sale of real estate properties | - | 840,036 |
| Total revenue | $3,477,664 | $3,673,997 |
| For the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue by geographic area: | ||
| Hong Kong | $2,178,761 | $2,046,846 |
| Malaysia | 336,539 | 397,705 |
| China | 962,364 | 1,229,446 |
| Total revenue | $3,477,664 | $3,673,997 |
Deferred costs of revenue
For a service contract where the performance obligation has not been completed, deferred costs of revenue is recorded for any costs incurred in advance before completion of the performance obligation.
Deferred revenue
For a service contract where the performance obligation has not been completed, deferred revenue is recorded for any payments received in advance before completion of the performance obligation.
As of December 31, 2023, and 2022, deferred costs of revenue or deferred revenue is classified as current assets or current liabilities and totaled, respectively:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Current assets | ||
| Deferred costs of revenue | $16,291 | $168,605 |
| Current liabilities | ||
| Deferred revenue | $1,075,404 | $1,834,244 |
Changes in deferred revenue during 2023 and 2022 are as follows:
| As of and for the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Deferred revenue, beginning of year | $1,834,244 | $2,006,696 |
| New contract liabilities | 1,179,938 | 1,133,171 |
| Performance obligations satisfied | (1,938,778) | (1,305,623) |
| Deferred revenue, end of year | $1,075,404 | $1,834,244 |
NOTE 3 -PROPERTY AND EQUIPMENT, NET
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Property and equipment | ||
| Office leasehold | $3,008,413 | $3,008,413 |
| Furniture and fixtures | 52,058 | 52,058 |
| Office equipment | 62,148 | 62,148 |
| Leasehold improvement | 92,566 | 92,566 |
| 3,215,185 | 3,215,185 | |
| Changes during the year: | ||
| Add: Additions | 85,069 | - |
| Less: Disposal | (4,353) | - |
| Property and equipment, gross ending | 3,295,901 | 3,215,185 |
| Less: Accumulated depreciation | ||
| Accumulated depreciation, beginning of year | (701,618) | (620,881) |
| Depreciation for the year | (118,963) | (125,486) |
| Disposal or write-off | 4,136 | - |
| Effect of changes in exchange rate | (65,918) | 44,749 |
| Accumulated depreciation, end of year | (882,363) | (701,618) |
| Property and equipment, net | $2,413,538 | $2,513,567 |
Office leasehold under property and equipment represents three adjoining office units owned and used by the Company located in a commercial building in Shenzhen, China. The office leasehold is subject to a 50-year land lease with a remaining term of 21 years and is being depreciated over the remaining lease term. Depreciation for this office leasehold in Shenzhen, China, classified as an operating expense, was $104,442 and $111,707 for the years ended December 31, 2023, and 2022, respectively.
Depreciation for property and equipment, including office leasehold, furniture and fixtures, office equipment and leasehold improvement, classified as an operating expense, totaled $118,963 and $125,486 for the years ended December 31, 2023, and 2022, respectively.
NOTE 4 -REAL ESTATE HELD FOR SALE
On December 31, 2023, and 2022, real estate held for sale was valued $1,659,207 and $1,659,207, respectively. Real estate held for sale represents multiple units in a building located in Hong Kong.
During 2023, no property was sold. For the year ended December 31, 2022, the Company sold three units for $840,036, with original cost of $408,813 and other costs of sale of $164,530.
The property was developed for resale on a “unit by unit” basis and is stated at the lower of cost or estimated fair value, less estimated costs to sell. Real estate held for sale represents properties for which a committed plan to sell exists and an active program to market such properties has been initiated.
NOTE 5 -REAL ESTATE HELD FOR INVESTMENT, NET
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Real estate held for investment | ||
| Office leasehold | $780,518 | $780,518 |
| Furniture and fixtures | 51,721 | 51,721 |
| Office equipment | 16,534 | 16,534 |
| Leasehold improvement | 70,906 | 70,906 |
| Real estate held for investment, gross | 919,679 | 919,679 |
| Less: Accumulated depreciation | ||
| Accumulated depreciation, beginning of year | (269,456) | (254,066) |
| Depreciation for the year | (25,125) | (29,001) |
| Effect of changes in exchange rate | (26,350) | 13,611 |
| Accumulated depreciation, end of year | (320,931) | (269,456) |
| Real estate held for investment, net | $598,748 | $650,223 |
Real estate held for investment represents the Company’s three office units located in two commercial buildings in Malaysia. The adjoining office units and the other office unit in another building are currently rented to an unrelated tenant, respectively.
Depreciation for real estate held for investment, included in the cost of rental revenue, was $25,125 and $29,001 for the years ended December 31, 2023, and 2022, respectively.
NOTE 6 -OTHER INVESTMENTS
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Investment in equity securities without readily determinable fair values of affiliates: | ||
| (1) Greenpro Trust Limited (a related party) | $11,981 | $11,981 |
| (2) Other related parties | 88,125 | 5,394,125 |
| Total | $100,106 | $5,406,106 |
Equity securities without readily determinable fair values are investments in privately held companies without readily determinable market values. The Company adopted the guidance of ASC 321, Investments - Equity Securities, which allows an entity to measure investments in equity securities without a readily determinable fair value using a measurement alternative that measures these securities at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investment of same issuer (the “Measurement Alternative”). The fair value of equity securities without readily determinable fair values that have been remeasured due to impairment are classified within Level 3. Management assesses each of these investments on an individual basis. Additionally, on a quarterly basis, management is required to make a qualitative assessment of whether the investment is impaired.
The Company believes all the invested equity securities are without readily determinable values even certain of the equity securities are listed in the over the counter (OTC) market, as their securities are not actively traded on a securities exchange registered with the U.S. Securities and Exchange Commission (SEC) or in the OTC market.
For the year ended December 31, 2023, the Company recognized impairment of $4,982,000 for three of its total investments in equity securities without readily determinable fair values and recorded a reversal of impairment of $6,882,000 for one of the total investments in equity securities without readily determinable fair values. For the year ended December 31, 2022, the Company recognized impairment of $4,208,029 for six of its total investments in equity securities without readily determinable fair values.
In addition, the Company recorded its equity securities without readily determinable fair values at cost. For these cost method investments, we recorded as other investments in our consolidated balance sheets. We reviewed all our cost method investments quarterly to determine if impairment indicators were present; however, we were not required to determine fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally adopt the valuation methods allowed under ASC820 Fair Value Measurement to evaluate the fair values of our cost method investments approximated or exceeded their carrying values.
As of December 31, 2023, the carrying value of our cost method investments aggregated $100,106.
On December 31, 2023, and 2022, the carrying values of equity securities without readily determinable fair values are as follows:
| As of As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Original cost | ||
| Balance, beginning of year | $15,537,964 | $15,545,764 |
| Additions during the year | 500 | 1,250 |
| Terminations, disposals or forfeitures during the year | (7,206,500) | (9,050) |
| Balance, end of year | 8,331,964 | 15,537,964 |
| Accumulated impairment | ||
| Balance, beginning of year | (10,131,858) | (5,923,829) |
| Impairment during the year | (4,982,000) | (4,208,029) |
| Reversal of impairment during the year | 6,882,000 | - |
| Balance, end of year | (8,231,858) | (10,131,858) |
| Net carrying values of equity securities without readily determinable fair values | $100,106 | $5,406,106 |
For the years ended December 31, 2023, and 2022, the Company recognized an impairment loss of other investments of $4,982,000 and $4,208,029, respectively.
During 2023, the Company terminated one of the investments with original cost of $7,206,000. As a result, a reversal of impairment of $6,882,000 was recorded for the year ended December 31, 2023.
During 2023, one investment was sold back to investee at cost of $500 and a new investment was acquired at $500, respectively.
Acquisition of other investments during 2023
Celmonze Wellness Corporation
On February 8, 2023, our wholly owned subsidiary, Greenpro Venture Capital Limited (“GVCL”) entered into a subscription agreement with Celmonze Wellness Corporation, a Nevada corporation, which provides beauty and wellness solutions to clients (“Celmonze”). Pursuant to the agreement, GVCL acquired 5,000,000 shares of common stock of Celmonze at a price of $500 or $0.0001 per share. The investment was recognized at a historical cost of $500 under other investments.
As of December 31, 2023, the Company recorded the investment in Celmonze at a historical cost of $500 under other investments.
Termination or disposal of other investments during 2023
| (a) | Termination |
|---|
Innovest Energy Fund
On February 11, 2021, Greenpro Resources Limited, a subsidiary of the Company (“GRL”) entered into a subscription agreement with Innovest Energy Fund, a global multi-asset fund incorporated in the Cayman Islands and principally engaged in developing a multi-faceted suite of products and services for the cryptocurrency industry and economy (the “Fund”). Pursuant to the agreement, GRL agreed to subscribe for $7,206,000 worth of Class B shares of the Fund by issuing 300,000 shares of the Company’s restricted Common Stock, valued at $7,206,000 to the Fund.
On May 18, 2023, the Company decided to terminate its investment in the Fund due to significant impairments suffered since subscription and to cancel the shares issued to the Fund due to the Fund’s failure to provide consideration for the shares. As a result,300,000 shares of the Company’s restricted Common Stock were cancelled, the value of Common Stock of $300 and the value of additional paid-in capital of $7,205,700, in aggregate of $7,206,000, were reversed accordingly. The Company recorded a reversal of impairment of other investment of $6,882,000 during the year ended December 31, 2023.
| (b) | Disposal |
|---|
Simson Wellness Tech Corp.
On February 19, 2021, GVCL entered into a subscription agreement with Simon Wellness Tech Corp., a Nevada corporation, which is a digital platform that acts as middleware for distribution of optical products (“Simson”). Pursuant to the agreement, GVCL acquired 5,000,000 shares of common stock of Simson at a price of $500 or $0.0001 per share. Our investment in Simson was recognized at historical cost of $500 under other investments.
In July 2023, GVCL agreed with Simson’s repurchase request, sold back our 5,000,000 owned Simson shares to Simson at $500. We received cash of $500 from Simson in exchange for our return of Simson shares.
Impairment of other investments during 2023
Millennium Fine Art Inc.
On June 29, 2020, the Company entered into a purchase and sale agreement with its Wyoming incorporated subsidiary, Millennium Fine Art Inc. (“MFAI”). Pursuant to the agreement, the Company agreed to sell its 4% ownership interest in a 12.3 kilogram carved natural blue sapphire (the “Millennium Sapphire”) to MFAI and MFAI agreed to acquire the 4% ownership of the Millennium Sapphire from the Company. As consideration thereto, on July 1, 2020, MFAI issued 2,000,000 restricted shares of its Class B common stock to the Company valued at $5,000,000 ($5 per share), in which 1,000,000 shares were retained by the Company and the other 1,000,000 shares were reserved as a dividend to the shareholders of the Company. The Company expects to distribute these 1,000,000 shares to its shareholders later. A gain on disposal of $1,000,000 was recorded at the Company level but was eliminated upon consolidation.
On July 1, 2020, MFAI issued 19,200,000 restricted shares of its Class A common stock to a majority owner of the Millennium Sapphire, Mr. Daniel McKinney valued at $96,000,000 ($5 per share) to acquire the remaining 96% interest in the Millennium Sapphire. MFAI is an investment company and has a 100% interest in the Millennium Sapphire.
As of December 31, 2022, the Company owns 2,000,000 shares of Class B common stock of MFAI, in which 1,000,000 shares were retained by the Company and recognized our investment in MFAI at historical cost of $4,000,000 (by issuance of 444,444 shares of the Company’s restricted Common Stock at $9 per share) under other investments, representing approximately 5% of the issued and outstanding shares of MFAI and approximately 1% of MFAI’s total voting rights.
The other 1,000,000 shares were reserved as a dividend to the shareholders of the Company, and as of the date of this report, the dividend has not been distributed.
For the year ended December 31, 2023, the Company made a full impairment of $4,000,000 for the investment in MFAI due to continuing losses incurred by MFAI and uncertainty of the existence of the Millennium Sapphire. As a result, our investment in MFAI was recorded with nil value as of December 31, 2023.
Ata Plus Sdn. Bhd.
On July 8, 2020, GVCL entered into an acquisition agreement with all the eight shareholders of Ata Plus Sdn. Bhd., a company incorporated in Malaysia and a Recognized Market Operator (RMO) by the Securities Commission of Malaysia (“APSB”). Pursuant to the agreement, GVCL agreed to acquire 15% of the issued and outstanding shares of APSB for a purchase price of $749,992. The purchase price was paid by the Company issuing to the shareholders approximately 45,731 shares of the Company’s restricted Common Stock, which was based on the average closing price of the Company’s Common Stock for the five trading days preceding the date of the agreement, $16.4 per share, on November 18, 2020.
As of December 31, 2022, the fair value of APSB was appraised by an independent appraiser, the Appraiser and according to our 15% interest in APSB, our investment was valued approximately $736,000. Hence, the Company recorded an impairment loss of $13,992 for the year ended December 31, 2022.
For the year ended December 31, 2023, the Company made a further impairment of $736,000 for the investment in APSB due to APSB’s continuing losses and the Company’s shareholdings in APSB were diluted from 15% to approximately 4% at the end of 2023. As a result, our investment in APSB was fully impaired with nil value as of December 31, 2023.
First Bullion Holdings, Inc.
On October 19, 2020, GVCL entered into a stock purchase and option agreement with Mr. Tang Ka Siu Johnny and First Bullion Holdings Inc. (“FBHI”). FBHI, a British Virgin Islands company, operates the businesses of banking, payment gateway, credit cards, debit cards, money lending, crypto trading, and securities token offerings, with corporate offices in the Philippines and Hong Kong. Pursuant to the agreement, GVCL agreed to acquire 10% of the issued and outstanding shares of FBHI for a purchase price of $1,000,000 by issuing approximately 68,587 shares of the Company’s restricted Common Stock to Mr. Tang, which was based on the average closing price of the Company’s Common Stock for the five trading days preceding the date of the agreement.
Pursuant to the agreement, Mr. Tang and FBHI also granted to GVCL an option for 180 days following the date of the agreement to purchase an additional 8% of the issued and outstanding shares of FBHI, at an agreed valuation of FBHI equal to $20,000,000. In consideration of acquisition of the option, GVCL agreed to issue 25,000 shares of the Company’s restricted Common Stock to Mr. Tang, which shall constitute partial payment for the option should GVCL elect to exercise the option.
On December 11, 2020, the Company issued 68,587 shares of its restricted Common Stock to two designees of Mr. Tang at $14.58 per share to acquire 10% of the issued and outstanding shares of FBHI for a purchase price of $1,000,000 and issued 25,000 shares of its restricted Common Stock at $364,500 or $14.58 per share in partial consideration of the additional 8% shareholdings of FBHI.
On February 17, 2021, GVCL exercised its option and FBHI issued to GVCL 160,000 ordinary shares of FBHI, comprising the additional 8% of the shares sold under the agreement valued at $20,000,000.
On February 26, 2021, the Company issued an additional 34,259 shares of its restricted Common Stock to two designees of Mr. Tang at $27 per share (valued at approximately $925,000). Therefore, GVCL, in aggregate, holds 360,000 ordinary shares of FBHI, representing 18% of the total issued and outstanding shares of FBHI. The investment was recognized at historical cost of $2,289,500 under other investments.
As of December 31, 2022, the fair value of FBHI was appraised the Appraiser and according to our 18% interest in FBHI, our investment was valued approximately $246,000. The depreciation of FHBI’s fair value was mainly due to a significant decrease of its revenue. Hence, the Company recorded an impairment loss of $2,043,500 for the year ended December 31, 2022.
For the year ended December 31, 2023, the Company made a further impairment of $246,000 for the investment in FBHI due to FBHI’s dormant status. As a result, our investment in FBHI was fully impaired with nil value as of December 31, 2023.
NOTE 7 -INTANGIBLE ASSETS AND GOODWILL
Intangible assets, net
| As of December 31, | ||
|---|---|---|
| Intangible assets | 2023 | 2022 |
| Trademarks | $7,253 | $7,253 |
| Customer lists | 344,500 | 344,500 |
| Insurance agency license | 129,032 | 129,032 |
| Total intangible assets, gross | 480,785 | 480,785 |
| Less: Accumulated amortization | ||
| Accumulated amortization, beginning of year | (478,885) | (478,160) |
| Amortization during the year | (718) | (718) |
| Effect of changes in exchange rate | (1) | (7) |
| Accumulated amortization, end of year | (479,604) | (478,885) |
| Intangible assets, net | $1,181 | $1,900 |
As of December 31, 2023, the original cost of our intangible assets totaled $480,785 which includes $7,253 of trademarks acquired by Greenpro Resources (HK) Limited (“GRHK”) during the years of 2013 to 2018, $344,500 of customer lists from the acquisition of Ace Corporation Services Limited (renamed to Falcon Corporate Services Limited on August 26, 2016) (“FCSL”) in 2015, and $129,032 of an insurance agency license from the acquisition of Sparkle Insurance Brokers Limited (renamed to Greenpro Sparkle Insurance Brokers Limited on April 4, 2019) (“Sparkle”) on January 2, 2019, respectively.
As of December 31, 2023, the customer lists from Ace and the insurance agency license from Sparkle had been fully amortized with nil value. During 2023, the Company conducted the annual impairment test and concluded that it is more likely than not the estimated fair value of the trademarks of GRHK was more than their carrying amount, and no impairment indicator existed. As a result, no impairment was made.
Amortization expense for intangible assets for the years ended December 31, 2023, and 2022 was $718, respectively.
Amortization for each year following December 31, 2023, is as follows:
| Year ending December 31, | Trademarks |
|---|---|
| 2024 | $718 |
| 2025 | 463 |
| Total | $1,181 |
As of December 31, 2023, the accumulated amortization of intangible assets was $479,604, and the net value of intangible assets was $1,181.
Goodwill
| As of December 31, | ||
|---|---|---|
| Goodwill | 2023 | 2022 |
| Falcon Accounting & Secretaries Limited | $319,726 | $319,726 |
| Greenpro Capital Village Sdn. Bhd. | 26,082 | 26,082 |
| Goodwill | 345,808 | 345,808 |
| Less: Accumulated impairment | ||
| Accumulated impairment, beginning of year | (263,247) | - |
| Impairment during the year | - | (263,247) |
| Accumulated impairment, end of year | (263,247) | (263,247) |
| Goodwill, after impairment | $82,561 | $82,561 |
The Company’s goodwill consisted of $319,726 from its acquisition of Falcon Secretaries Limited (renamed to Falcon Accounting & Secretaries Limited on February 25, 2020) (“FASL”) in 2015 and $26,082 from its acquisition of Greenpro Capital Village Sdn. Bhd. (“GCVSB”) in 2021, respectively. Collectively, the Company’s goodwill totaled $345,808.
Goodwill is not amortized but tested for any indicator of impairment annually.
During 2022, the Company conducted the annual impairment test for FASL and GCVSB, respectively and concluded that there was an indicator of impairment for the goodwill derived from the acquisition of FASL, as the net asset value (“NAV”) of FASL is less than the value of the goodwill as of December 31, 2022. As a result, an impairment loss of $263,247 was made, the value of the Company’s goodwill was impaired to $82,561, represents the value of goodwill related to FASL was impaired to $56,479 and the value of goodwill related to GCVSB remains at $26,082, respectively.
During 2023, the Company conducted the annual impairment test and concluded that there was no indicator of impairment for the goodwill derived from the acquisitions of FASL and GCVSB, as both the NAV of FASL and GCVSB was greater than the respective value of the goodwill as of December 31, 2023.
For the years ended December 31, 2023, and 2022, $0 and $263,247 of impairment of goodwill was made, respectively.
As of December 31, 2023, the value of the Company’s goodwill remains at $82,561, representing the value of goodwill related to FASL of $56,479 and the value of goodwill related to GCVSB of $26,082, respectively.
NOTE 8 -LEASES
As of December 31, 2023, the Company has an operating lease agreement for one office space in Hong Kong with a term oftwo years and has a finance lease for a motor vehicle in Malaysia with a term offive years, respectively. Other than these leases, the Company does not have any other leases over the term of one year. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company accounts for the lease and non-lease components of its leases as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.
Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of interest (“discount rate”) in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.
The components of lease costs and supplemental cash flow information related to operating leases and finance leases are as follows:
| For the years ended December 31, | |||
|---|---|---|---|
| 2023 · 2022 | |||
| Lease costs | |||
| Operating lease costs: | |||
| Rental expenses (1) | $94,999 | $85,989 | |
| Other rental expenses (2) | 19,402 | 26,915 | |
| Total Operating lease costs | 114,401 | 112,904 | |
| Finance lease costs: | |||
| Interest expenses | $729 | $ | - |
| Total Finance lease costs | 729 | - | |
| Total lease costs | $115,130 | $112,904 | |
| Other information | |||
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Rental payment - operating leases | $96,211 | $91,919 | |
| Interest repayment - finance leases | 729 | - | |
| Principal repayment - finance leases | 1,902 | - | |
| Total cash paid | $98,842 | $91,919 | |
| Non-cash activity: | |||
| Balance payment of ROU asset by finance lease liabilities | $18,957 | $ | - |
| Weighted average remaining lease term (in years): | |||
| Operating leases | 1.20 | 0.21 | |
| Finance leases | 4.42 | - | |
| Weighted average discount rate: | |||
| Operating leases | 4.0% | 4.0% | |
| Finance leases | 6.9% | - | |
| (1) | Rental expenses include amortization of $89,695 and $83,297 and interest expenses of $5,304 and $2,692 for the years ended December 31, 2023, and 2022, respectively. |
| (2) | Other rental expenses represent those rental expenses for leases with a lease term within one year, and government rent and rates related to the leases. |
The supplemental balance sheet information related to leases during the past two years is as follows:
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Long-term operating lease ROU assets, net (1) | $114,551 | $17,510 |
| Long-term finance lease ROU asset, net (2) | 25,527 | - |
| Total ROU assets | $140,078 | $17,510 |
| Liabilities | ||
| Current portion of operating lease liabilities | $94,726 | $18,725 |
| Current portion of finance lease liabilities | 3,426 | - |
| Total current lease liabilities | 98,152 | 18,725 |
| Long-term operating lease liabilities | 19,825 | - |
| Long-term finance lease liabilities | 13,638 | - |
| Total long-term lease liabilities | 33,463 | - |
| Total lease liabilities | $131,615 | $18,725 |
| (1) | Operating lease ROU assets are measured at cost of $351,829 and $164,771 less accumulated amortization of $237,278 and $147,261 as of December 31, 2023, and 2022, respectively. |
| (2) | Finance lease ROU asset is measured at cost of $28,898 less accumulated amortization of $3,371 as of December 31, 2023. |
Maturities of the Company’s lease liabilities as of December 31, 2023 are as follows:
| Operating leases · Finance leases | ||
|---|---|---|
| Year ending December 31, | ||
| 2024 | 97,583 | 4,490 |
| 2025 | 19,936 | 4,490 |
| 2026 | - | 4,490 |
| 2027 | - | 4,490 |
| 2028 | - | 1,868 |
| Total future minimum lease payments | 117,519 | 19,828 |
| Less: Imputed interest/present value discount | (2,968) | (2,764) |
| Present value of lease liabilities | $114,551 | $17,064 |
| Lease obligations | ||
| Current lease obligations | $94,726 | $3,426 |
| Long-term lease obligations | 19,825 | 13,638 |
| Total lease obligations | $114,551 | $17,064 |
For the year ended December 31, 2023, total lease costs were $115,130 including operating lease costs of $114,401 and finance lease costs of $729, respectively. During 2022, total lease costs were the operating lease costs of $112,904.
NOTE 9 -DERIVATIVE LIABILITIES
| As of and for the years ended, | |||
|---|---|---|---|
| 2023 · 2022 | |||
| Fair value at beginning of year | $1 | $9,935 | |
| Fair value gains of derivative liability associated with warrants | (1) | (9,934) | |
| Fair value at end of year | $ | - | $1 |
Warrants
On June 12, 2018, warrants exercisable into 53,556 shares of the Company’s Common Stock were issued as placement agent fees related to the Company’s sale of Common Stock (see Note 11). The strike price of warrants issued by the Company is denominated in US dollars. As a result, the warrants are not considered indexed to the Company’s own stock, and the Company characterized the fair value of the warrants as a derivative liability upon issuance. The derivative liability is re-measured at the end of every reporting period with the change in value reported in the statement of operations.
On July 19, 2022, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada (the “Certificate of Change”), to effect a reverse split of the Company’s Common Stock at a ratio of 10-for-1 (the “Reverse Stock Split”), effective as of July 28, 2022. The Reverse Stock Split effected a reduction in the number of shares of Common Stock issuable upon the exercise of the warrants outstanding immediately prior to the effectiveness of the Reverse Stock Split. As a result of the Reverse Stock Split, the number of the outstanding warrants exercisable into the Company’s Common Stock was reduced from 53,556 (pre-split) shares to 5,356 (post-split) shares (see Note 11).
Warrant activity including the number of shares and the exercise price per share has been adjusted for all periods presented in this Annual Report to reflect the Reverse Stock Split effected on July 28, 2022, on a retroactive basis.
At December 31, 2023, the Company did not have any outstanding warrants exercisable into the Company’s Common Stock as all call warrants were not exercised on June 12, 2023 (the “Expiration”). At the Expiration, the Company’s Common Stock traded at or below the exercise price (120% of the public offering price), that is $72 (post-split) per share or $7.2 (pre-split) per share.
During the year ended December 31, 2023, the Company recorded a decrease in fair value of derivatives of $1.
The balance of the derivative liabilities related to warrants was $0 and $1 at December 31, 2023 and 2022, respectively.
The derivative liabilities were valued using the Black-Scholes-Merton valuation model with the following assumptions:
| As of June 12, 2023 (expiration) · As of December 31, 2022 | |||
|---|---|---|---|
| Risk-free interest rate | $3.87% | $3.97% | |
| Expected volatility | 162% | 168% | |
| Contractual life (in years) | 0.0 years | 0.4 years | |
| Expected dividend yield | 0.00% | 0.00% | |
| Fair value of warrants | $ | - | $1 |
The risk-free interest rate is based on the yield available on U.S. Treasury securities. The Company estimates volatility based on the historical volatility of its Common Stock. The expected life of the warrants is based on the expiration date of the warrants. The expected dividend yield was based on the fact the Company has not paid dividends to common shareholders in the past and does not expect to pay dividends to common shareholders in the future.
On June 12, 2023 (the “Expiration), no warrants were exercised as the trading price of the Company’s Common Stock was at or below the exercise price of $72 (post-split) per share or $7.2 (pre-split) per share. At the Expiration, the closing price of the Company’s Common Stock was $1.78 per share.
For the year ended December 31, 2023, the Company recognized a gain of $1 associated with the revaluation of above derivative liability.
NOTE 10 -STOCKHOLDERS’ EQUITY
Our authorized capital consists, of 600,000,000 shares, of which 500,000,000 shares are designated as shares of Common Stock, par value $0.0001 per share, and 100,000,000 shares are designated as shares of preferred stock, par value $0.0001 per share. No shares of preferred stock are currently outstanding. Shares of preferred stock may be issued in one or more series, each series to be appropriately designated by a distinguishing letter or title, prior to the issuance of any shares thereof. The voting powers, designations, preferences, limitations, restrictions, relative, participating, options and other rights, and the qualifications, limitations, or restrictions thereof, of the preferred stock are to be determined by the Board of Directors before the issuance of any shares of preferred stock in such series.
Cancellation of shares in 2023
On February 11, 2021, Greenpro Resources Limited, a subsidiary of the Company (“GRL”) entered into a subscription agreement with Innovest Energy Fund, a global multi-asset fund incorporated in the Cayman Islands and principally engaged in developing a multi-faceted suite of products and services for the cryptocurrency industry and economy (the “Fund”). Pursuant to the agreement, GRL agreed to subscribe for $7,206,000 worth of Class B shares of the Fund by issuing 300,000 shares of the Company’s restricted Common Stock, valued at $7,206,000 to the Fund.
On May 18, 2023, the Company decided to terminate its investment in the Fund due to significant impairments suffered since subscription and to cancel the shares issued to the Fund due to the Fund’s failure to provide consideration for the shares. As a result,300,000 shares of the Company’s restricted Common Stock were cancelled, the value of Common Stock of $300 and the value of additional paid-in capital of $7,205,700, in aggregate of $7,206,000, were reversed accordingly.
Reverse stock split in 2022
On July 19, 2022, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada (the “Certificate of Change”), to effect a reverse split of the Company’s Common Stock at a ratio of 10-for-1 (the “Reverse Stock Split”), effective as of July 28, 2022. On that date, every 10 issued and outstanding shares of the Company’s Common Stock were automatically converted into one outstanding share of Common Stock.
The Reverse Stock Split affected all holders of Common Stock uniformly and did not affect any stockholder’s percentage of ownership interest. The par value of the Company’s Common Stock remained unchanged at $0.0001 per share and the number of authorized shares of Common Stock remained the same after the Reverse Stock Split.
As the par value per share of the Company’s Common Stock remained unchanged at $0.0001 per share, the change in the Common Stock recorded at par value has been reclassified to additional paid-in-capital on a retroactive basis. All references to shares of Common Stock and per share data for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted to reflect the Reverse Stock Split on a retroactive basis.
During 2023 and 2022, the Company did not any issue any shares of its Common Stock.
NOTE 11–WARRANTS
On June 13, 2018, the Company granted to the placement agent and issued warrants exercisable into 53,556 shares of Common Stock at an exercise price of $7.20 per share and the expected expiration of the warrants is June 12, 2023 (the “Expiration”). Since the Expiration, the Company does not expect to issue other warrants in the next twelve months.
On July 19, 2022, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada (the “Certificate of Change”) to effect a reverse split of the Company’s Common Stock at a ratio of 10-for-1 (the “Reverse Stock Split”), effective as of July 28, 2022. The Reverse Stock Split effected a reduction in the number of shares of Common Stock issuable upon the exercise of the warrants outstanding immediately prior to the effectiveness of the Reverse Stock Split. As a result of the Reverse Stock Split, the number of the outstanding warrants exercisable into the Company’s Common Stock was reduced from 53,556 (pre-split) shares to 5,356 (post-split) shares (see Note 9) and the exercise price of the warrants was adjusted from $7.2 (pre-split) per share to $72 (post-split) per share.
Warrant activity including the number of shares and the exercise price per share has been adjusted for all periods presented in this Quarterly Report to reflect the Reverse Stock Split effected on July 28, 2022 on a retroactive basis.
A summary of warrants to purchase Common Stock issued during the years ended December 31, 2023, and 2022 is as follows:
| Shares · Weighted Average Exercise Price | |||
|---|---|---|---|
| Balance outstanding as of January 1, 2022 | 5,356 | $72 | |
| Granted | - | - | |
| Exercised | - | - | |
| Expired | - | - | |
| Balance outstanding and exercisable as of December 31, 2022 | 5,356 | 72 | |
| Granted | - | - | |
| Exercised | - | - | |
| Expired | (5,356) | (72) | |
| Balance outstanding and exercisable as of December 31, 2023 | - | $ | - |
On June 12, 2023 (the “Expiration), no warrants were exercised as the trading price of the Company’s Common Stock was at or below the exercise price of $72 (post-split) per share or $7.2 (pre-split) per share. At the Expiration, the closing price of the Company’s Common Stock was $1.78 per share.
At of December 31, 2023, the value of the warrants was $nil as all warrants expired, and hence, no warrants were outstanding and exercisable.
NOTE 12-INCOME TAXES
Provision for income taxes consisted of the following:
| For the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Current: | ||
| – Local · $ · - · $ · - | ||
| – Foreign: | ||
| Hong Kong | - | - |
| The PRC | 6,829 | 2,356 |
| Malaysia | - | - |
| Deferred: | ||
| – Local | - | - |
| – Foreign | - | - |
| $6,829 | $2,356 | |
A summary of local (United States) and foreign loss before income taxes was comprised of the following:
| For the years ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Tax jurisdictions from: | ||
| – United States | $(4,093,463) | $(727,898) |
| – Foreign, representing: | ||
| Hong Kong | (345,251) | 73,114 |
| The PRC | (265) | 248,199 |
| Malaysia | (47,494) | (101,077) |
| Labuan | (342,489) | (42,826) |
| Other (primarily nontaxable jurisdictions) | 5,885,490 | (5,709,344) |
| Income (loss) before income taxes | $1,056,528 | $(6,259,832) |
Effective and Statutory Rate Reconciliation
The following table summarizes a reconciliation of the Company’s statutory income tax rate to the Company’s effective tax rate as a percentage of income from continuing operations before taxes:
| For the years ended December 31, | ||||
|---|---|---|---|---|
| 2023 · 2022 | ||||
| Statutory tax rate | 21.0% | 21.0% | ||
| Impairment of goodwill, intangible assets, and investments | - | % | - | % |
| Change in income tax valuation allowance | (20.3)% | (21.0)% | ||
| Effective tax rate | 0.7% | 0.0% | ||
The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. During the years presented, the Company has several subsidiaries that operate in different countries and are subject to tax in the jurisdictions in which its subsidiaries operate, as follows:
The significant components of deferred taxes of the Company are as follows (rounded to the nearest thousand):
| As of December 31, | ||||
|---|---|---|---|---|
| 2023 · 2022 | ||||
| Deferred tax assets | ||||
| Impairment of goodwill, intangible assets, and investments | $832,000 | $832,000 | ||
| Financing costs | 974,000 | 974,000 | ||
| Operating lease liability | 24,000 | 4,000 | ||
| Finance lease liability | 4,000 | - | ||
| Accounts receivable allowance | 128,000 | 5,000 | ||
| Net operating loss (NOL) carryforwards: | ||||
| – United States of America | 4,778,000 | 3,918,000 | ||
| – Hong Kong | 558,000 | 504,000 | ||
| – The PRC | 559,000 | 557,000 | ||
| – Malaysia | 226,000 | 217,000 | ||
| – Labuan | 12,000 | 1,000 | ||
| Gross deferred tax assets | 8,095,000 | 7,012,000 | ||
| Less: valuation allowance | (8,066,000) | (7,006,000) | ||
| Total deferred tax assets | 29,000 | 6,000 | ||
| Deferred tax liabilities | ||||
| Change in fair value of derivative liabilities | - | 2,000 | ||
| Operating lease right-of-use asset | 24,000 | 4,000 | ||
| Finance lease right-of-use asset | 5,000 | - | ||
| Total deferred tax liabilities | 29,000 | 6,000 | ||
| Net deferred tax asset (liability) | $ | - | $ | - |
The Company believes that it is more likely than not that the deferred tax assets will not be fully realized in the future. Accordingly, the Company established a valuation allowance of $8,066,000 to offset deferred tax assets of $8,095,000 including deferred tax assets related to net operating loss (NOL) carryforwards of $6,133,000 as of December 31, 2023.
For the year ended December 31, 2023, the valuation allowance increased by $1,060,000, was primarily due to an increase of net operating loss (NOL) carryforwards from various tax regimes.
United States of America
The Company is registered in the State of Nevada and is subject to United States of America tax law.
For the years ended December 31, 2023, and 2022, the operations in the United States of America incurred a net operating loss (NOL) of $4,093,000 and $728,000, respectively.
As of December 31, 2023, the cumulative net operating losses (NOLs) were $22,753,000 which can be carried forward to offset future taxable income. The NOL carryforwards begin to expire in 2037, if unutilized.
Hong Kong
The Company’s subsidiaries operating in Hong Kong are subject to the Hong Kong Profits Tax at the statutory income tax rate of 16.5% on their assessable income for the tax year.
For the year ended December 31, 2023, the subsidiaries in Hong Kong incurred the aggregate of a net operating loss (NOL) of $345,000 while for the year ended December 31, 2022, the subsidiaries in Hong Kong incurred the aggregate of a net operating income (NOI) of $73,000.
As of December 31, 2023, the cumulative net operating losses (NOLs) aggregated for those subsidiaries which have operations in Hong Kong were $2,651,000. The cumulative NOLs can be carried forward indefinitely to offset future taxable income.
The PRC
The Company’s subsidiaries operating in the PRC are subject to the Corporate Income Tax governed by the Income Tax Law of the People’s Republic of China with a unified statutory income tax rate of 25%.
For the year ended December 31, 2023, the subsidiaries in the PRC recorded the aggregate of a net operating loss (NOL) approximately of $0, while for the year ended December 31, 2022, the subsidiaries in the PRC recorded the aggregate of a net operating income (NOI) of $248,000.
As of December 31, 2023, the subsidiaries operating in the PRC had incurred the aggregate amount of cumulative net operating losses (NOLs) of $2,236,000 which can be carried forward to offset future taxable income. A partial NOL carryforwards begin to expire in 2024, if unutilized.
Malaysia
The Company’s subsidiaries operating in Malaysia are subject to the Malaysia Corporate Tax Laws at an income tax rate from 15% to 24% on their assessable income for the tax year.
For the years ended December 31, 2023, and 2022, the subsidiaries in Malaysia incurred the aggregate of a net operating loss (NOL) of $47,000 and $101,000, respectively.
As of December 31, 2023, the operations in Malaysia had incurred the aggregate amount of cumulative net operating losses (NOLs) of $1,132,000 which can be carried forward indefinitely to offset taxable income in future.
Labuan
The Company’s subsidiary operating in Labuan is subject to the Labuan Corporate Tax Laws at a progressive income tax rate starting from 3% on their assessable income for the tax year.
For the years ended December 31, 2023, and 2022, the subsidiary in Labuan incurred the aggregate of a net operating loss (NOL) of $342,000 and $43,000, respectively.
As of December 31, 2023, the operations in Labuan had incurred the aggregate amount of cumulative net operating losses (NOLs) of $385,000 which can be carried forward indefinitely to offset taxable income in future.
The Company has provided for a full valuation allowance against the deferred tax assets on the expected future tax benefits from all the Company’s net operating loss carryforwards as the Company believes it is more likely than not that these deferred tax assets will not be fully realized in the future.
NOTE 13-RELATED PARTY TRANSACTIONS
| Accounts receivable from related parties: · December 31, 2023 · December 31, 2022 | |||
|---|---|---|---|
| Accounts receivable, net | |||
| - Related party B (net of allowance of $379,542 and $1,750 as of December 31, 2023, and 2022, respectively) | $ | - | $129,250 |
| - Related party K (net of allowance of $0 and $2 as of December 31, 2023, and 2022, respectively) | - | 42 | |
| Total | $ | - | $129,292 |
| Prepaid to a related party: · December 31, 2023 · December 31, 2022 | |||
|---|---|---|---|
| Prepayment | |||
| - Related party B | $ | - | $80,000 |
| Due from related parties: | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Due from related parties | ||
| - Related party B | $25,932 | $4,708 |
| - Related party D | 723,889 | 200,000 |
| - Related party G | 1,032 | 1,064 |
| - Related party H | - | 60,000 |
| - Related party I | 7 | - |
| Total | $750,860 | $265,772 |
The amounts due from related parties are interest-free, unsecured and have no fixed terms of repayment.
| Due to related parties: | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Due to related parties | ||
| - Related party A | $30,238 | $47,135 |
| - Related party B | 19,906 | 2,275 |
| - Related party E | 844 | - |
| - Related party J | 336,636 | 390,333 |
| - Related party K | 1,650 | 8,508 |
| Total | $389,274 | $448,251 |
The amounts due to related parties are interest-free, unsecured and repayable on demand.
| Deferred cost of revenue to a related party: · December 31, 2023 · December 31, 2022 | |||
|---|---|---|---|
| Deferred cost of revenue to a related party | |||
| - Related party B | $ | - | $11,640 |
| Deferred revenue from related parties: | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Deferred revenue from related parties | ||
| - Related party B | $157,500 | $749,400 |
| - Related party E | - | 100,000 |
| Total | $157,500 | $849,400 |
| For the years ended December 31, | ||||
|---|---|---|---|---|
| Income from or expenses to related parties: · 2023 · 2022 | ||||
| Service revenue from related parties | ||||
| - Related party A | $3,647 | $147,269 | ||
| - Related party B | 1,120,805 | 463,304 | ||
| - Related party D | 35,358 | 30,923 | ||
| - Related party E | 258,251 | 8,865 | ||
| - Related party G | 7,351 | 13,664 | ||
| - Related party I | - | 1,089 | ||
| - Related party K | 165 | 89 | ||
| Total | $1,425,577 | $665,203 | ||
| Cost of revenues to a related party | ||||
| - Related party B | $23,280 | $ | - | |
| General and administrative expenses to related parties | ||||
| - Related party A | $ | - | $9,287 | |
| - Related party B | 24,844 | 125,286 | ||
| - Related party D | 44,475 | - | ||
| - Related party I | 15,762 | 16,334 | ||
| - Related party K | 37,799 | 42,895 | ||
| Total | $122,880 | $193,802 | ||
| Other income from related parties | ||||
| - Related party B | $38,747 | $1,356 | ||
| - Related party D | 8,862 | 4,494 | ||
| Total | $47,609 | $5,850 | ||
| Reversal of impairment of related party investment: | ||||
| - Related party B | $6,882,000 | $ | - | |
| Impairment of related party investments: | ||||
| - Related party B | $4,982,000 | $4,208,029 | ||
| Impairment of other receivable from related parties: | ||||
| - Related party D | $ | - | $606,250 | |
| - Related party H | 60,000 | - | ||
| Total | $60,000 | $606,250 | ||
Related party A is under common control of Mr. Loke Che Chan Gilbert, the Company’s CFO, and a major shareholder.
Related party B represents companies wherethe Company owns a respective percentage ranging from 1% to 18% interests in those companies.
Related party C is controlled by a director of some wholly owned subsidiaries of the Company.
Related party D represents companies that we have determined that we can significantly influence based on our common business relationships.
Related party E represents companies whose CEO is a consultant to the Company, and who is also a director of Aquarius Protection Fund and a shareholder of the Company.
Related party F represents a family member or members of Mr. Loke Che Chan Gilbert, the Company’s CFO, and a major shareholder.
Related party G is under common control of Mr. Lee Chong Kuang, the Company’s CEO and a major shareholder.
Related party H represents a company in which we currently have an approximate 48% equity-method investment. On December 31, 2023, the Company determined the amount due from related party H of $60,000 was impaired and recorded an impairment of other receivable of $60,000 for the year ended December 31, 2023. During 2018, the Company acquired approximately 49% of related party H for total consideration of $368,265. On December 31, 2018, the Company determined that its investments in related party H was impaired and recorded an impairment of other investments of $368,265.
Related party I is controlled by a family member of Mr. Lee Chong Kung, the Company’s CEO, and a major shareholder.
Related party J represents the noncontrolling interest in the Company’s subsidiary that owns its real estate held for sale. The amounts due to related party J are unsecured, bear no interest, are payable on demand, and related to the initial acquisition of the real estate held for sale.
Related party K represents shareholders and directors of the Company. Due from related party K represents the amounts paid by the Company to third parties on behalf of our shareholders or directors. On the other hand, due to related party K represents the amounts paid by the shareholders or directors to third parties on behalf of the Company. The amounts due from or due to related party K are non-interest bearing, and are due on demand.
NOTE 14 -SEGMENT INFORMATION
ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements.
The Company hastwo reportable segments that are based on the following business units: service business and real estate business. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company.
Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. The Company operates two reportable business segments:
| ● | Service business – provision of corporate advisory and business solution services |
|---|---|
| ● | Real estate business – trading or leasing of commercial real estate properties in Hong Kong and Malaysia |
The Company had no inter-segment sales for the years presented. Summarized financial information concerning the Company’s reportable segments is shown as below:
(a) By Categories
| Real estate business · Service business · Corporate · Total | ||||||
|---|---|---|---|---|---|---|
| Revenues | $98,068 | $3,379,596 | $ | - | $3,477,664 | |
| Cost of revenues | (36,613) | (534,965) | - | (571,578) | ||
| Reversal of impairment of investment | - | - | 6,882,000 | 6,882,000 | ||
| Reversal of write-off notes receivable | - | - | 600,000 | 600,000 | ||
| Depreciation and amortization | (29,982) | (207,520) | (386) | (237,888) | ||
| Impairment of other receivable | - | - | (60,000) | (60,000) | ||
| Impairment of investments | - | - | (4,982,000) | (4,982,000) | ||
| Net income (loss) | (59,715) | (857,609) | 1,967,023 | 1,049,699 | ||
| Total assets | 1,703,618 | 5,189,914 | 1,764,488 | 8,658,020 | ||
| Capital expenditures for long-lived assets | $ | - | $113,967 | $ | - | $113,967 |
| Real estate business · Service business · Corporate · Total | ||||||
|---|---|---|---|---|---|---|
| Revenues | $948,531 | $2,725,466 | $ | - | $3,673,997 | |
| Cost of revenues | (619,426) | (404,077) | - | (1,023,503) | ||
| Reversal of write-off notes receivable | - | - | 200,000 | 200,000 | ||
| Depreciation and amortization | (30,874) | (203,508) | (4,120) | (238,502) | ||
| Impairment of goodwill | - | - | (263,247) | (263,247) | ||
| Impairment of other receivable | - | - | (606,250) | (606,250) | ||
| Impairment of investments | - | - | (4,208,029) | (4,208,029) | ||
| Net income (loss) | 221,712 | (620,880) | (5,863,020) | (6,262,188) | ||
| Total assets | 1,851,373 | 5,995,114 | 7,792,719 | 15,639,206 | ||
| Capital expenditures for long-lived assets | $ | - | $3,016 | $ | - | $3,016 |
(b) By Geography*
| Hong Kong | Malaysia | China | Total | |
|---|---|---|---|---|
| Revenues* | $2,178,761 | $336,539 | $962,364 | $3,477,664 |
| Cost of revenues* | (272,758) | (169,245) | (129,575) | (571,578) |
| Reversal of impairment of investment* | 6,882,000 | - | - | 6,882,000 |
| Reversal of write-off notes receivable* | 600,000 | - | - | 600,000 |
| Depreciation and amortization* | (97,231) | (34,263) | (106,394) | (237,888) |
| Impairment of other receivable* | (60,000) | - | - | (60,000) |
| Impairment of investments* | (4,882,000) | - | - | (4,882,000) |
| Net income (loss)* | 1,252,158 | (517,533) | 315,074 | 1,049,699 |
| Total assets* | 4,499,800 | 1,534,064 | 2,624,156 | 8,658,020 |
| Capital expenditures for long-lived assets* | $1,549 | $110,869 | $1,549 | $113,967 |
| Hong Kong · Malaysia · China · Total | |||||
|---|---|---|---|---|---|
| Revenues* | $2,046,846 | $397,705 | $1,229,446 | $3,673,997 | |
| Cost of revenues* | (659,126) | (221,442) | (142,935) | (1,023,503) | |
| Reversal of write-off notes receivable* | 200,000 | - | - | 200,000 | |
| Depreciation and amortization* | (94,237) | (30,874) | (113,391) | (238,502) | |
| Impairment of goodwill* | (263,247) | - | - | (263,247) | |
| Impairment of other receivable* | (606,250) | - | - | (606,250) | |
| Impairment of investments* | (4,208,029) | - | - | (4,208,029) | |
| Net income (loss)* | (6,329,749) | (178,618) | 246,179 | (6,262,188) | |
| Total assets* | 10,786,359 | 1,969,298 | 2,883,549 | 15,639,206 | |
| Capital expenditures for long-lived assets* | $ | - | $1,226 | $1,790 | $3,016 |
| * | Revenues and costs are attributed to countries based on the location of customers. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.